Search

everythinglearnresearchcommunity

for

Search:↓

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Anabolic steroid users may face higher risk of severe COVID-19.

A man developed neurological issues from SARS-CoV-2 without severe breathing problems, worsening to death.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Multimedia education greatly improves women's knowledge and management of PCOS.

Six months of treatment improved PCOS symptoms and reduced AMH levels.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Many people experience hair loss after weight loss surgery, especially younger women, and it's linked to lower levels of zinc, folic acid, and ferritin.

ADAM17 could be a potential target for treating PCOS.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

The internet has accurate information on Polycystic Ovarian Syndrome, but it's not high quality or easy to read, so we need better, user-friendly resources.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

Myo-inositol plus α-lactalbumin works better than myo-inositol alone for improving symptoms of PCOS.

Magnesium supplements improved quality of life for women with polycystic ovary syndrome, but didn't help with acne, hair loss, or abnormal bleeding.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.

Newly found stem cells in horse hooves show promise for treating a hoof disease called laminitis.